EZH2-overexpression has been recently described within the context of MM, demonstrating its negative prognostic value: specifically, authors have reported on increased EZH2 during disease progression, going from MGUS, to smoldering myeloma, to MM [40]. This evidence concerns the gene EZH2 and plasma cell myeloma.